Susan Ngo Vuong
Finanzdirektor/CFO bei Bay City Capital LLC
Profil
Susan Vuong is the Chief Financial Officer and Chief Compliance Officer at Bay City Capital where she manages the financial and treasury operations, as well as the accounting and tax reporting for all Bay City Capital entities.
Ms. Vuong has over 25 years of accounting and finance experience.
Prior to her current position, Ms. Vuong served as the Controller for Bay City Capital for thirteen years and as Assistant Controller at Spectrum Equity for almost two years.
Before that, she was a Senior Accountant at Episcopal Homes Foundation, an Accountant at Anderegg Builders and an Accounting Assistant at A.G.
Spanos Construction, Inc. Ms. Vuong received a BA in Business Administration, with emphasis in Accounting, at the University of the Pacific.
Aktive Positionen von Susan Ngo Vuong
| Unternehmen | Position | Beginn |
|---|---|---|
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finanzdirektor/CFO | 01.06.2015 |
Imidomics, Inc.
 Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Finanzdirektor/CFO | 01.10.2020 |
Ehemalige bekannte Positionen von Susan Ngo Vuong
| Unternehmen | Position | Ende |
|---|---|---|
A.G. Spanos Cos.
 A.G. Spanos Cos. HomebuildingConsumer Durables A.G. Spanos Cos. develops and sells residential buildings. Its projects include multi-family communities, master planned communities, and the preserve. The company was founded by Alexander Gus Spanos in 1960 and is headquartered in Stockton, CA. | Corporate Officer/Principal | - |
Ausbildung von Susan Ngo Vuong
| University of the Pacific | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
A.G. Spanos Cos.
A.G. Spanos Cos. HomebuildingConsumer Durables A.G. Spanos Cos. develops and sells residential buildings. Its projects include multi-family communities, master planned communities, and the preserve. The company was founded by Alexander Gus Spanos in 1960 and is headquartered in Stockton, CA. | Consumer Durables |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Health Technology |
